Jaguar Health, Inc. ( JAGX) - Key Metrics
JAGX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $39.30 | $16.67 | $17.12 | $17.12 |
| 2025Q4 | $16.23 | -$115.69 | -$27.80 | -$27.66 |
| 2025Q3 | $71.31 | -$219.79 | -$108.46 | -$109.71 |
| 2025Q2 | $102.75 | -$358.95 | -$213.60 | -$213.60 |
| 2025Q1 | $123.66 | -$584.45 | -$408.62 | -$408.62 |
JAGX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 0% | -0.24 |
| 2025Q4 | 0% | -0.07 |
| 2025Q3 | 0% | -0.09 |
| 2025Q2 | 0% | -0.06 |
| 2025Q1 | 0% | -0.07 |
JAGX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 131.99% | 0% |
| 2025Q4 | -84.87% | 0% |
| 2025Q3 | -134.53% | 0% |
| 2025Q2 | -242.18% | 0% |
| 2025Q1 | -245.27% | 0% |
JAGX
Price: $0.87
52 week price:
Payout Ratio Range:
Earnings Per Share: -695.50 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 617552
Ebitda: -16.5 millionMarket Capitalization: 3.8 million